Peritonitis  >>  ciprofloxacin (Q3939)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT01670435: Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

Completed
N/A
3274
Japan
Ciprofloxacin (BAYQ3939)
Bayer
Infection
06/10
10/10
NCT01690559: Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Completed
N/A
704
Japan
Cipro (Ciprofloxacin, BAYQ3939)
Bayer
Infection
01/12
01/12

Download Options